Chimerix (CMRX)
(Delayed Data from NSDQ)
$0.88 USD
+0.02 (1.74%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $0.86 -0.02 (-1.71%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Income Statements
Fiscal Year end for Chimerix, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 34 | 2 | 5 | 13 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 33 | 2 | 5 | 13 |
Selling & Adminstrative & Depr. & Amort Expenses | 93 | 94 | 175 | 50 | 129 |
Income After Depreciation & Amortization | -93 | -60 | -173 | -45 | -116 |
Non-Operating Income | 11 | 233 | 0 | 1 | 3 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -82 | 172 | -173 | -44 | -113 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -82 | 172 | -173 | -44 | -113 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -82 | 172 | -173 | -44 | -113 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -100 | -62 | -172 | -44 | -117 |
Depreciation & Amortization (Cash Flow) | -7 | -1 | 1 | 0 | -1 |
Income After Depreciation & Amortization | -93 | -60 | -173 | -45 | -116 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 88.60 | 88.78 | 84.93 | 62.18 | 55.50 |
Diluted EPS Before Non-Recurring Items | -0.93 | 1.94 | -1.01 | -0.70 | -0.86 |
Diluted Net EPS (GAAP) | -0.93 | 1.94 | -2.04 | -0.70 | -2.03 |
Fiscal Year end for Chimerix, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.13 | 0.00 | 0.00 | 0.01 | 0.03 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.13 | 0.00 | 0.00 | 0.01 | 0.03 |
SG&A, R&D, and Dept/Amort Expenses | 22.96 | 24.39 | 20.81 | 26.70 | 21.38 |
Income After SG&A, R&D, and Dept/Amort Expenses | -22.83 | -24.39 | -20.81 | -26.69 | -21.35 |
Non-Operating Income | 2.15 | 2.52 | 2.65 | 2.70 | 2.77 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -20.69 | -21.87 | -18.16 | -23.99 | -18.58 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -20.69 | -21.87 | -18.16 | -23.99 | -18.58 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -20.69 | -21.87 | -18.16 | -23.99 | -18.58 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 89.63 | 89.26 | 88.91 | 88.62 | 88.58 |
Diluted EPS Before Non-Recurring Items | -0.23 | -0.25 | -0.20 | -0.27 | -0.21 |
Diluted Net EPS (GAAP) | -0.23 | -0.25 | -0.21 | -0.27 | -0.21 |